These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 10092062

  • 1. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
    Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T, Eguchi K.
    Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
    [Abstract] [Full Text] [Related]

  • 2. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
    Kobayashi M, Kawano S, Hatachi S, Kurimoto C, Okazaki T, Iwai Y, Honjo T, Tanaka Y, Minato N, Komori T, Maeda S, Kumagai S.
    J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome.
    Manganelli P, Quaini F, Andreoli AM, Lagrasta C, Pilato FP, Zuccarelli A, Monteverdi R, D'Aversa C, Olivetti G.
    J Rheumatol; 1997 Aug; 24(8):1552-7. PubMed ID: 9263150
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lymphoproliferative disorders in Sjögren's syndrome.
    Masaki Y, Sugai S.
    Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.
    Masago R, Aiba-Masago S, Talal N, Zuluaga FJ, Al-Hashimi I, Moody M, Lau CA, Peck AB, Brayer J, Humphreys-Beher MG, Dang H.
    Arthritis Rheum; 2001 Mar; 44(3):693-702. PubMed ID: 11263785
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Sjögren's syndrome as a lymphoaggressive disorder; bcl-2 expression in lymphocytes infiltrated in salivary glands].
    Takeshita S, Sugai S.
    Nihon Rinsho; 1995 Oct; 53(10):2440-5. PubMed ID: 8531352
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line.
    Kawakami A, Nakashima K, Tamai M, Nakamura H, Iwanaga N, Fujikawa K, Aramaki T, Arima K, Iwamoto N, Ichinose K, Kamachi M, Ida H, Origuchi T, Eguchi K.
    J Rheumatol; 2007 May; 34(5):1019-26. PubMed ID: 17407216
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
    Zhang X, Li L, Choe J, Krajewski S, Reed JC, Thompson C, Choi YS.
    Cell Immunol; 1996 Oct 10; 173(1):149-54. PubMed ID: 8871610
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjogren's syndrome.
    Aziz KE, McCluskey PJ, Montanaro A, Wakefield D.
    J Clin Lab Immunol; 1992 Jan 10; 37(1):39-49. PubMed ID: 1339235
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.